Sun Pharmaceutical Industries Limited

SUNPHARMA

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 20266,142

    Quarter₹ croreYoY
    Sept 20245,128+0.6%
    Dec 20246,192+22.0%
    Mar 20257,186+27.4%
    Jun 20255,602+24.5%
    Sept 20254,548-11.3%
    Dec 20255,688-8.1%
    Mar 20264,924-31.5%
    Jun 20265,741+2.5%
    Sept 20266,142+35.0%
  • ₹ crore

    Sept 202681

    Quarter₹ crore
    Sept 202486
    Dec 202468
    Mar 2025132
    Jun 2025104
    Sept 202573
    Dec 2025180
    Mar 202663
    Jun 2026140
    Sept 202681
  • ₹ crore

    Sept 20266,223

    Quarter₹ crore
    Sept 20245,214
    Dec 20246,260
    Mar 20257,318
    Jun 20255,706
    Sept 20254,621
    Dec 20255,868
    Mar 20264,987
    Jun 20265,881
    Sept 20266,223
  • Cost structure
  • ₹ crore

    Sept 2026852

    Quarter₹ crore
    Sept 2024662
    Dec 2024652
    Mar 2025649
    Jun 2025715
    Sept 2025729
    Dec 2025740
    Mar 2026704
    Jun 2026831
    Sept 2026852
  • ₹ crore

    Sept 20265,020

    Quarter₹ crore
    Sept 20244,318
    Dec 20244,995
    Mar 20254,706
    Jun 20254,233
    Sept 20253,949
    Dec 20254,512
    Mar 20264,138
    Jun 20264,363
    Sept 20265,020
  • Exceptional items and tax
  • ₹ crore

    Sept 20261,203

    Quarter₹ crore
    Sept 2024896
    Dec 20241,265
    Mar 20252,612
    Jun 20251,185
    Sept 2025672
    Dec 20251,097
    Mar 2026849
    Jun 20261,486
    Sept 20261,203
  • ₹ crore

    Sept 2026332

    Quarter₹ crore
    Sept 202432
    Dec 202484
    Mar 2025612
    Jun 2025431
    Sept 2025108
    Dec 2025392
    Mar 2026240
    Jun 2026371
    Sept 2026332
  • Profit
  • ₹ crore

    Sept 2026871

    Quarter₹ croreYoY
    Sept 2024863-2.9%
    Dec 20241,181+63.7%
    Mar 20252,000+130.6%
    Jun 2025754+216.8%
    Sept 2025564-34.6%
    Dec 2025705-40.3%
    Mar 2026609-69.6%
    Jun 20261,115+48.0%
    Sept 2026871+54.4%
  • Per share
  • ₹ per share

    Sept 20263.60

    Quarter₹ per share
    Sept 20243.60
    Dec 20244.90
    Mar 20258.30
    Jun 20253.10
    Sept 20252.40
    Dec 20252.90
    Mar 20262.50
    Jun 20264.60
    Sept 20263.60
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
5,1286,1927,1865,6024,5485,6884,9245,7416,142
Revenue YoY+0.6%+22.0%+27.4%+24.5%-11.3%-8.1%-31.5%+2.5%+35.0%
8668132104731806314081
5,2146,2607,3185,7064,6215,8684,9875,8816,223
Cost structure
662652649715729740704831852
4,3184,9954,7064,2333,9494,5124,1384,3635,020
Exceptional items and tax
8961,2652,6121,1856721,0978491,4861,203
3284612431108392240371332
Profit
8631,1812,0007545647056091,115871
Net profit YoY-2.9%+63.7%+130.6%+216.8%-34.6%-40.3%-69.6%+48.0%+54.4%
Per share
3.604.908.303.102.402.902.504.603.60

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.